Literature DB >> 27585647

An update on the epigenetics of glioblastomas.

Wallax Augusto Silva Ferreira1, Danilo do Rosário Pinheiro1, Carlos Antonio da Costa Junior1, Symara Rodrigues-Antunes1, Mariana Diniz Araújo1, Mariceli Baia Leão Barros1, Adriana Corrêa de Souza Teixeira1, Thamirys Aline Silva Faro1, Rommel Rodriguez Burbano2, Edivaldo Herculano Correa de Oliveira3, Maria Lúcia Harada1, Bárbara do Nascimento Borges1.   

Abstract

Glioblastomas, also known as glioblastoma multiforme (GBM), are the most aggressive and malignant type of primary brain tumor in adults, exhibiting notable variability at the histopathological, genetic and epigenetic levels. Recently, epigenetic alterations have emerged as a common hallmark of many tumors, including GBM. Considering that a deeper understanding of the epigenetic modifications that occur in GBM may increase the knowledge regarding the tumorigenesis, progression and recurrence of this disease, in this review we discuss the recent major advances in GBM epigenetics research involving histone modification, glioblastoma stem cells, DNA methylation, noncoding RNAs expression, including their main alterations and the use of epigenetic therapy as a valid option for GBM treatment.

Entities:  

Keywords:  DNA methylation; astrocytomas; biomarkers; brain tumors; cancer; epigenetic regulation; genetic; glioblastoma; gliomas; targeted therapy

Mesh:

Substances:

Year:  2016        PMID: 27585647     DOI: 10.2217/epi-2016-0040

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

1.  The Epigenetic Regulation of OLIG2 by Histone Demethylase KDM6B in Glioma Cells.

Authors:  Aixia Sui; Biaogang Han; Wenjun Ren; Weiliang He; Chao Gao; Xiaohui Han; Shifeng Liu; Yan Zhang; Xueling Qi; Xiaoqiang Guo
Journal:  J Mol Neurosci       Date:  2022-02-07       Impact factor: 3.444

2.  Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States.

Authors:  Rebecca L Achey; Haley Gittleman; Julia Schroer; Vishesh Khanna; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

Review 3.  Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020.

Authors:  Manuela Rocha de Menezes; Maria Eduarda Azevêdo Acioli; Ana Carolina Lemos da Trindade; Suéllen Pedrosa da Silva; Raul Emídio de Lima; Vanessa Gabryelle da Silva Teixeira; Luydson Richardson Silva Vasconcelos
Journal:  Mol Biol Rep       Date:  2021-05-25       Impact factor: 2.316

4.  Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.

Authors:  Lin Sun; Yinlong Kong; Manqing Cao; Hongyuan Zhou; Huikai Li; Yunlong Cui; Feng Fang; Wei Zhang; Jiafeng Li; Xiaolin Zhu; Qiang Li; Tianqiang Song; Ti Zhang
Journal:  Cancer Sci       Date:  2017-05-20       Impact factor: 6.716

5.  BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.

Authors:  Andrew L Kung; Rajeev Vibhakar; Adam L Green; John DeSisto; Patrick Flannery; Rakeb Lemma; Aaron Knox; Madeleine Lemieux; Bridget Sanford; Rebecca O'Rourke; Shakti Ramkissoon; Kristen Jones; Jennifer Perry; Xu Hui; Erin Moroze; Ilango Balakrishnan; Allison F O'Neill; Katherine Dunn; Deborah DeRyckere; Etienne Danis; Aaron Safadi; Ahmed Gilani; Benjamin Hubbell-Engler; Zachary Nuss; Jean M Mulcahy Levy; Natalie Serkova; Sujatha Venkataraman; Douglas K Graham; Nicholas Foreman; Keith Ligon; Ken Jones
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

6.  PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma.

Authors:  Haoyu Li; Qing Liu; Kai Xiao; Zhengxi He; Chao Wu; Jianjun Sun; Xin Chen; Suhua Chen; Jun Yang; Qianquan Ma; Jun Su
Journal:  Onco Targets Ther       Date:  2021-01-08       Impact factor: 4.147

7.  Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 8.  Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.

Authors:  Elisabeth Naderlinger; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2017-05-17       Impact factor: 4.096

Review 9.  Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies.

Authors:  Zoltan Kraboth; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2019-08-03       Impact factor: 3.201

10.  Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.

Authors:  Giulia Stazi; Ludovica Taglieri; Alice Nicolai; Annalisa Romanelli; Rossella Fioravanti; Stefania Morrone; Manuela Sabatino; Rino Ragno; Samanta Taurone; Marcella Nebbioso; Raffaella Carletti; Marco Artico; Sergio Valente; Susanna Scarpa; Antonello Mai
Journal:  Clin Epigenetics       Date:  2019-12-02       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.